| A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma (NCT07439653) | TORL Biotherapeutics, LLC | 2026-03-31 |
| A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors (NCT07407933) | MediLink Therapeutics (Suzhou) Co., Ltd. | 2026-03-31 |
| A Study to Learn About the Effect of Study Medicine Called PF-08653944 on How Quickly the Stomach Empties Its Content in Healthy Adults With Overweight or Obesity (NCT07508241) | Pfizer | 2026-03-31 |
| A PhaseⅠ Study of HW252001 in Healthy Subjects (NCT07493031) | Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. | 2026-03-31 |
| A Study of SKB575 (HBM7575) Injection in Healthy Participants and Atopic Dermatitis Participants (NCT07488065) | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2026-03-31 |
| A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC (NCT07462377) | EpiBiologics | 2026-03-31 |
| A Phase I Dose Escalation and Dose Expansion Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Durvalumab (NCT07391670) | AstraZeneca | 2026-03-31 |
| Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants (NCT07444788) | University Hospital, Basel, Switzerland | 2026-03-31 |
| BC3195 in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors (NCT07469774) | Biocity Biopharmaceutics Co., Ltd. | 2026-03-31 |
| AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors (NCT07454642) | Avacta Life Sciences Ltd | 2026-03-31 |
| A Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Heart Disease (NCT07495813) | Hoffmann-La Roche | 2026-03-31 |
| A Study to Assess Adverse Events, Tolerability, and Pharmacokinetics of Subcutaneous Injections of ABBV-295 in Healthy Adult Japanese Participants With Overweight or Obesity. (NCT07514260) | AbbVie | 2026-03-31 |
| Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic(PK/PD) Profile of ACT500 in Metabolic Dysfunction-Associated Steatotic Liver Disease(MASLD) (NCT07462455) | Xiamen Amoytop Biotech Co., Ltd. | 2026-03-31 |
| LPM6690176 in Combination With Chemotherapy and Bevacizumab in Metastatic Colorectal Cancer Patients With RAS Mutation (NCT07391566) | Luye Pharma Group Ltd. | 2026-03-31 |
| A Phase I Study of SIM0532 in Adult Participants With Advanced Solid Tumors (NCT07749703) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2026-03-31 |
| Study of IBI3028 in Participants With Locally Advanced, Unresectable, or Metastatic Solid Tumors (NCT07589205) | Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. | 2026-03-31 |
| Mindfulness Meditation for Insomnia (NCT06972303) | Brigham and Women's Hospital | 2026-03-31 |
| A Research Study Looking at How NNC0487-0111 Affects Food Intake, Appetite and Metabolism After Meals in People With Obesity (NCT07508020) | Novo Nordisk A/S | 2026-03-30 |
| Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer (NCT07042919) | Devalingam Mahalingam | 2026-03-30 |
| A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077) (NCT07199465) | Merck Sharp & Dohme LLC | 2026-03-30 |
| A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1043 in Healthy Adult Participants Living With Overweight and/or Obesity. (NCT07511205) | AstraZeneca | 2026-03-30 |
| Study Evaluating the Safety, Efficacy and Pharmacokinetics of SYH9089 Injection in Patients Undergoing Abdominal Surgery. (NCT07519109) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2026-03-30 |
| A Phase Ib Study of HS-10504 Combined Therapy in NSCLC (NCT07414953) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2026-03-30 |
| A Phase I Clinical Trial to Evaluate the Pharmacokinetic and Safety of Ammoxetine Hydrochloride Enteric-Coated Tablets in Participants With Mild Hepatic Impairment, Moderate Hepatic Impairment, and Normal Liver Function (NCT07694843) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2026-03-30 |
| BOLD-100 Plus Doxorubicin in Advanced Soft Tissue Sarcomas (NCT07027423) | University Health Network, Toronto | 2026-03-30 |
| PROTECT-Study: Prospective Research on Optimizing Atropine Concentration Escalation for Children's Myopia Prevention (NCT07449247) | Tianjin Medical University Eye Hospital | 2026-03-30 |
| Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma (NCT07535710) | Shanghai Jiao Tong University School of Medicine | 2026-03-30 |
| A Study of Multiple Doses of Orally Administered RO7795081 in Otherwise Healthy Chinese Adult Participants With Obesity or Overweight (NCT07499050) | Hoffmann-La Roche | 2026-03-30 |
| Dihydroartemisinin for MAFLD (NCT07679542) | The First Affiliated Hospital with Nanjing Medical University | 2026-03-30 |
| Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian Cancer (NCT07736937) | Tubulis GmbH | 2026-03-30 |
| HIV Therapeutic DNA Vaccine (ICVAX) Phase I Clinical Trial in Hong Kong (NCT07530198) | Immuno Cure Holding (HK) Limited | 2026-03-30 |
| Early-phase Trial to Assess the Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors (NCT07455734) | BioNTech SE | 2026-03-30 |
| PS-002 for the Treatment of IgA Nephropathy in Adults (NCT07182227) | Purespring Therapeutics Limited | 2026-03-30 |
| MDMA in Subjects With Moderate Hepatic Impairment and Subjects With Normal Hepatic Function (NCT03606538) | Resilient Pharmaceuticals | 2026-03-29 |
| Study of QLS5308 in Patients With Advanced Solid Tumors (NCT07462442) | Qilu Pharmaceutical Co., Ltd. | 2026-03-28 |
| NBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung Cancer (NCT07224152) | M.D. Anderson Cancer Center | 2026-03-27 |
| A Phase 1 Randomized, Observer-blind, Placebo-controlled, Dose-escalation Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-MARV-GP Vaccine in Adults in Good General Health (NCT07425821) | International AIDS Vaccine Initiative | 2026-03-27 |
| A Study of [14C]-LY4064809 in Healthy Participants (NCT07519525) | Eli Lilly and Company | 2026-03-27 |
| A Study of HRS-6208 in Combination With HRS-8080, or Fulvestrant, or Letrozole, With or Without HRS-6209 in Patients With Advanced Unresectable or Metastatic Breast Cancer (NCT07389733) | Shandong Suncadia Medicine Co., Ltd. | 2026-03-27 |
| An Open-Label, Phase I Clinical Trial of Super CAR-T With GPC3-Positive Advanced Hepatocellular Carcinoma (NCT07493044) | Guangzhou FineImmune Biotechnology Co., LTD. | 2026-03-27 |
| A Study to Evaluate Efficacy and Safety of HB0043 in Aadult Patients With Moderate to Severe Acne Vulgaris. (NCT07449156) | Shanghai Huaota Biopharmaceutical Co., Ltd. | 2026-03-27 |
| A Phase 1 Study to Assess the Effect of ABBV-722 on Ethinyl Estradiol and Levonorgestrel Drug Levels in Healthy Adult Female Participants (NCT07502417) | AbbVie | 2026-03-27 |
| Emavusertib (CA-4948) in Combination With Cisplatin, Gemcitabine, and Durvalumab in Patients With Untreated Advanced or Metastatic Biliary Tract Cancer (NCT07107750) | Washington University School of Medicine | 2026-03-27 |
| A Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F) (NCT07405151) | Merck Sharp & Dohme LLC | 2026-03-27 |
| A 2-part Phase 1/2 Open-label Trial on ODM-212 (NCT07563738) | Orion Corporation, Orion Pharma | 2026-03-27 |
| A Study to Investigate the Effects of JMKX003142 on QTc Interval in Healthy Adults (NCT07470177) | Jemincare | 2026-03-27 |
| A Clinical Study for the Efficacy and Safety of BL0020 Injection in Patients With Small Cell Lung Cancer Transformed From Non-Small Cell Lung Cancer Following EGFR TKI Therapy (NCT07414927) | Shanghai Best-Link Bioscience, LLC | 2026-03-27 |
| Safety and Efficacy of SC101 Via Perirenal Fat Injection for Resistant Hypertension in Patients With Moderate to Severe Chronic Kidney Disease (NCT07483372) | The First Affiliated Hospital with Nanjing Medical University | 2026-03-27 |
| Intratumoral Injection of Recombinant Human Endostatin Adenovirus (EDS01) for the Treatment of Recurrent or Metastatic Head and Neck Tumors (NCT07625423) | West China Hospital | 2026-03-27 |
| Phase Ib Study of CD33 FPBMC in Patients With MRD+ AML or MDS (NCT07270978) | University of Virginia | 2026-03-26 |
| A Study of BGM0504 Tablets in Healthy Chinese Subjects (NCT07566572) | BrightGene Bio-Medical Technology Co., Ltd. | 2026-03-26 |
| Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma (NCT07388563) | National Cancer Institute (NCI) | 2026-03-26 |
| How [14C]-DSP-5336 is Absorbed, Broken Down, and Removed From the Body After a Single Oral Dose in Patients With Advanced Blood Cancers (NCT07444268) | Sumitomo Pharma America, Inc. | 2026-03-26 |
| A Trial to Study if REGN17372 in Combination With Linvoseltamab is Tolerable for Adult Participants With Relapsed/Refractory Multiple Myeloma (NCT07455851) | Regeneron Pharmaceuticals | 2026-03-26 |
| Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of ALXN2230 in Healthy Participants (NCT07352423) | Alexion Pharmaceuticals, Inc. | 2026-03-26 |
| A Phase 1b Study of Adenylosuccinic Acid (ASA-001) for Adenylosuccinate Synthase 1 (ADSS1) Deficient Myopathy. (NCT07412821) | Cure ADSSL1 | 2026-03-26 |
| A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208) (NCT07293351) | Bristol-Myers Squibb | 2026-03-26 |
| Study of Hydroxynidone Capsules in Patients With Hepatic Impairment and Matched Healthy Controls (NCT07394309) | Beijing Continent Pharmaceutical Co, Ltd. | 2026-03-25 |
| Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]GRT6019 (NCT07479745) | Grünenthal GmbH | 2026-03-25 |
| A Preliminary Clinical Study on the Efficacy of Cyclophosphamide and Sirolimus Combined With VIC-1911 in Preventing Graft-versus-Host Disease After Haploidentical Stem Cell Transplantation in Children (NCT07350057) | Shanghai Jiao Tong University School of Medicine | 2026-03-25 |
| Study of TRX-100 Evaluating the Safety, Pharmacokinetics, and Food Effect in Healthy Volunteers (NCT07526506) | Traws Pharma, Inc. | 2026-03-25 |
| Neoadjuvant Therapy With Ensartinib Combined With Chemotherapy for ALK-positive Non - Small Cell Lung Cancer (NSCLC) (NCT07354061) | Tang-Du Hospital | 2026-03-25 |
| ONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma (NCT06904378) | Washington University School of Medicine | 2026-03-25 |
| Acute Nicotine Gum and Tinnitus Loudness in Non-Smoking Adults (NCT07772089) | Xianhui Wang | 2026-03-25 |
| Clinical Trial to Evaluate the Safety and Immunogenicity of the V2 Apex-Directed Immunogens DV201P-RNA and DV202B1-RNA in Adult Participants Without HIV (NCT07390474) | National Institute of Allergy and Infectious Diseases (NIAID) | 2026-03-25 |
| A Study of BL-M24D1 in Patients With Relapsed or Refractory Multiple Myeloma and Other Hematologic Malignancies (NCT07255898) | Sichuan Baili Pharmaceutical Co., Ltd. | 2026-03-25 |
| PhIbRandomGemcitabine(G)w/or w/Out Pitavastatin(P)MainTx UnresecPancreaticAdenocarcinoma(uPDAC) (NCT07549958) | University of California, Irvine | 2026-03-24 |
| Anterior Cruciate Ligament (ACL) Reconstruction With Autologous Fat Pad Derived Mesenchymal Stem Cells (NCT06798623) | The Methodist Hospital Research Institute | 2026-03-24 |
| A Study to Assess Effect of Dosing Intervals on Multiple-Dose Pharmacokinetics of WD-1603 Taken Before Meals in Healthy Participants (NCT07442591) | Shanghai WD Pharmaceutical Co., Ltd. | 2026-03-24 |
| A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19. (NCT07445971) | ModeX Therapeutics, An OPKO Health Company | 2026-03-24 |
| Study of ABO2102 in KRAS-Mutated Solid Tumors (NCT07455617) | Suzhou Abogen Biosciences Co., Ltd. | 2026-03-24 |
| A Study of HRS-2129 in Patients With Diabetic Peripheral Neuropathic Pain (NCT07377721) | Shandong Suncadia Medicine Co., Ltd. | 2026-03-24 |
| Response-Based Dose Reduction of Linvoseltamab in the Treatment of Relapsed, Refractory, or Triple-Class Relapsed/Refractory Multiple Myeloma (NCT07181941) | Fred Hutchinson Cancer Center | 2026-03-24 |
| A Study of Mirikizumab Solution (LY3074828) in Healthy Participants (NCT07446101) | Eli Lilly and Company | 2026-03-24 |
| Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity (NCT06431932) | Ove Andersen | 2026-03-24 |
| Pilot Testing a Novel Approach to Pediatric Obesity Treatment (NCT06755827) | Texas Tech University | 2026-03-24 |
| A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK) (NCT07401875) | M.D. Anderson Cancer Center | 2026-03-24 |
| RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas (NCT07506668) | Affiliated Hospital of Nantong University | 2026-03-23 |
| A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ME3241 Administered Intravenously in Healthy Adult Participants (NCT07422207) | Meiji Pharma USA Inc. | 2026-03-23 |
| Study of Low-Intensity Focused Ultrasound in Combination With Immunotherapy in Newly Diagnosed Unmethylated Glioblastoma (NCT07343986) | University of Virginia | 2026-03-23 |
| A Phase 1 Study of HB2198 in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE) (NCT07491900) | Hinge Bio | 2026-03-23 |
| A Study to Assess the Bioavailability and Adhesion of Selegiline TDS in Healthy Subjects (NCT07571824) | Corium Innovations, Inc. | 2026-03-23 |
| Anthocyanin-Rich Table Grape Powder for Prophylaxis of Post-Operative Atrial Fibrillation (NCT05991700) | University of Michigan | 2026-03-23 |
| A Clinical Study of the Effect of Enlicitide (MK-0616) Formulations in Healthy Participants (MK-0616-041) (NCT07481708) | Merck Sharp & Dohme LLC | 2026-03-23 |
| First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors (NCT07438782) | GlaxoSmithKline | 2026-03-23 |
| A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fed Conditions (NCT07470866) | Pfizer | 2026-03-23 |
| Genotype-guided Targeted Agents Plus EZH2i for Primary Refractory PTCL (NCT07493330) | Ruijin Hospital | 2026-03-23 |
| DXP-106 in Solid Tumor Patients. (NCT07532018) | Singlomics Biopharmaceuticals Zhuhai Co., Ltd. | 2026-03-23 |
| Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer (NCT07128680) | City of Hope Medical Center | 2026-03-23 |
| A Trial to Investigate the Safety of E303 in Participants With Advanced Refractory Solid Tumors (NCT07524348) | Samsung Bioepis Co., Ltd. | 2026-03-23 |
| KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer (NCT07353645) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2026-03-23 |
| Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients. (NCT07064005) | Pravat Mandal | 2026-03-23 |
| Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of IY-828026 in Healthy Volunteers (NCT07433556) | Il-Yang Pharm. Co., Ltd. | 2026-03-23 |
| A Study of JPH034 in Healthy Adult Participants (NCT07534657) | J-Pharma Co., Ltd. | 2026-03-22 |
| A Single Centre, Open-label, 2-period Fixed-sequence, Phase I Clinical Study to Evaluate the Effect of BV100 on the Pharmacokinetics of Polymyxin B in Healthy Volunteers (NCT07580586) | BioVersys SAS | 2026-03-22 |
| Safety and Preliminary Efficacy of Organic Whole Psilocybin-Containing Mushrooms to Treat Patients Suffering From PTSD (NCT07275970) | Scottsdale Research Institute | 2026-03-20 |
| A Challenge Study to Assess the Blood-stage Efficacy of Full-length SUM-101 Malaria Vaccine Candidate (NCT07124156) | European Vaccine Initiative | 2026-03-20 |
| A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234 (NCT07546760) | AstraZeneca | 2026-03-20 |
| A Phase I Clinical Trial to Assess the Safety and Immunogenicity of DX-104 (NCT07395739) | Shanghai Yuguan Biotech Co., Ltd.（Delonix Bioworks) | 2026-03-20 |
| Study of NTX-2001 on Alcohol Consumption in Alcohol Use Disorder (NCT07520292) | Newleos Therapeutics, Inc. | 2026-03-20 |